Company Description
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
The company is headquartered in Bannockburn, Illinois.
| Country | United States |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 8,266 |
| CEO | John Rademacher |
Contact Details
Address: 3000 Lakeside Drive, Suite 300N Bannockburn, Illinois 60015 United States | |
| Phone | 312 940 2443 |
| Website | optioncarehealth.com |
Stock Details
| Ticker Symbol | OPCH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1014739 |
| CUSIP Number | 68404L201 |
| ISIN Number | US68404L2016 |
| Employer ID | 05-0489664 |
| SIC Code | 8082 |
Key Executives
| Name | Position |
|---|---|
| John Charles Rademacher | Chief Executive Officer, President and Director |
| Meenal Anil Sethna CPA | Executive Vice President and Chief Financial Officer |
| Luke Whitworth | Chief Operating Officer |
| Collin G. Smyser | General Counsel and Corporate Secretary |
| Christopher L. Grashoff | Chief Growth Officer |
| Nicole Maggio | Senior Vice President, Controller and Principal Accounting Officer |
| Brett Michalak | Chief Technology Officer |
| Alyssa Moy | Chief Information Officer |
| Stacey Mahone | Senior Vice President and Chief Compliance Officer |
| Jorge Ramirez | Senior Vice President of Strategy and Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 12, 2026 | 8-K | Current Report |
| May 6, 2026 | SCHEDULE 13G/A | Filing |
| May 5, 2026 | 8-K | Current Report |
| Apr 30, 2026 | 10-Q | Quarterly Report |
| Apr 30, 2026 | SCHEDULE 13G | Filing |
| Apr 30, 2026 | 8-K | Current Report |
| Apr 29, 2026 | SCHEDULE 13G | Filing |
| Apr 8, 2026 | ARS | Filing |
| Apr 8, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2026 | DEF 14A | Other definitive proxy statements |